Literature DB >> 24332981

Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.

Pamela D Thompson1, Amos Sakwe1, Rainelli Koumangoye2, Wendell G Yarbrough3, Josiah Ochieng1, Dana R Marshall4.   

Abstract

This study was performed to identify the potential role of Alpha-2 Heremans Schmid Glycoprotein (AHSG) in Head and Neck Squamous Cell Carcinoma (HNSCC) tumorigenesis using an HNSCC cell line model. HNSCC cell lines are unique among cancer cell lines, in that they produce endogenous AHSG and do not rely, solely, on AHSG derived from serum. To produce our model, we performed a stable transfection to down-regulate AHSG in the HNSCC cell line SQ20B, resulting in three SQ20B sublines, AH50 with 50% AHSG production, AH20 with 20% AHSG production and EV which is the empty vector control expressing wild-type levels of AHSG. Utilizing these sublines, we examined the effect of AHSG depletion on cellular adhesion, proliferation, migration and invasion in a serum-free environment. We demonstrated that sublines EV and AH50 adhered to plastic and laminin significantly faster than the AH20 cell line, supporting the previously reported role of exogenous AHSG in cell adhesion. As for proliferative potential, EV had the greatest amount of proliferation with AH50 proliferation significantly diminished. AH20 cells did not proliferate at all. Depletion of AHSG also diminished cellular migration and invasion. TGF-β was examined to determine whether levels of the TGF-β binding AHSG influenced the effect of TGF-β on cell signaling and proliferation. Whereas higher levels of AHSG blunted TGF-β influenced SMAD and ERK signaling, it did not clearly affect proliferation, suggesting that AHSG influences on adhesion, proliferation, invasion and migration are primarily due to its role in adhesion and cell spreading. The previously reported role of AHSG in potentiating metastasis via protecting MMP-9 from autolysis was also supported in this cell line based model system of endogenous AHSG production in HNSCC. Together, these data show that endogenously produced AHSG in an HNSCC cell line, promotes in vitro cellular properties identified as having a role in tumorigenesis.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AHSG; Adhesion; HNSCC; Invasion; MMP-9; Metastasis; Migration; TGF-β

Mesh:

Substances:

Year:  2013        PMID: 24332981      PMCID: PMC4096485          DOI: 10.1016/j.yexcr.2013.12.003

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  33 in total

Review 1.  Head and neck cancer.

Authors:  A Forastiere; W Koch; A Trotti; D Sidransky
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

2.  Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.

Authors:  Constanze Ondruschka; Peter Buhtz; Christiane Motsch; Bernd Freigang; Regine Schneider-Stock; Albert Roessner; Carsten Boltze
Journal:  Pathol Res Pract       Date:  2002       Impact factor: 3.250

3.  Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist.

Authors:  M Demetriou; C Binkert; B Sukhu; H C Tenenbaum; J W Dennis
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

Review 4.  TGF-beta signaling in tumor suppression and cancer progression.

Authors:  R Derynck; R J Akhurst; A Balmain
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

5.  Rapid release of intracellular galectin-3 from breast carcinoma cells by fetuin.

Authors:  W Q Zhu; J Ochieng
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

6.  Alpha 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis.

Authors:  Maria L Leite-Browning; Lisa J McCawley; Willi Jahnen-Dechent; Lloyd E King; Lynn M Matrisian; Josiah Ochieng
Journal:  Int J Oncol       Date:  2004-08       Impact factor: 5.650

7.  Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A.

Authors:  Madappa N Kundranda; Sanhita Ray; Margaret Saria; David Friedman; Lynn M Matrisian; Pavel Lukyanov; Josiah Ochieng
Journal:  Biochim Biophys Acta       Date:  2004-08-23

8.  alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.

Authors:  Carol J Swallow; Emily A Partridge; Jennifer C Macmillan; Tania Tajirian; Gianni M DiGuglielmo; Kazy Hay; Melanie Szweras; Willi Jahnen-Dechent; Jeff L Wrana; Mark Redston; Steven Gallinger; James W Dennis
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

9.  Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells.

Authors:  Ruchadaporn Kaomongkolgit
Journal:  Odontology       Date:  2012-07-26       Impact factor: 2.634

10.  Members of the cystatin superfamily interact with MMP-9 and protect it from autolytic degradation without affecting its gelatinolytic activities.

Authors:  Sanhita Ray; Pavel Lukyanov; Josiah Ochieng
Journal:  Biochim Biophys Acta       Date:  2003-12-01
View more
  10 in total

Review 1.  Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes.

Authors:  Josiah Ochieng; Gladys Nangami; Amos Sakwe; Cierra Moye; Joel Alvarez; Diva Whalen; Portia Thomas; Philip Lammers
Journal:  Int J Mol Sci       Date:  2018-07-29       Impact factor: 5.923

2.  Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high-grade astrocytomas.

Authors:  Gladys N Nangami; Amos M Sakwe; Michael G Izban; Tanu Rana; Philip E Lammers; Portia Thomas; Zhenbang Chen; Josiah Ochieng
Journal:  Cancer Med       Date:  2016-11-23       Impact factor: 4.452

3.  GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.

Authors:  Chang Liu; Zhi Li; Lu Xu; Yu Shi; Xiaojie Zhang; Sha Shi; Kezuo Hou; Yibo Fan; Ce Li; Xiaoxun Wang; Lu Zhou; Yunpeng Liu; Xiujuan Qu; Xiaofang Che
Journal:  Aging (Albany NY)       Date:  2020-06-18       Impact factor: 5.682

4.  Roles Of EAAT1, DHFR, And Fetuin-A In The Pathogenesis, Progression And Prognosis Of Chondrosarcoma.

Authors:  Lile He; Xiangyu Shi; Zhongyue Liu; Xiaolei Ren; Chenghao Zhang; Zhulin Yang; Zhihong Li
Journal:  Onco Targets Ther       Date:  2019-10-14       Impact factor: 4.147

5.  Identification of potential salivary biomarker panels for oral squamous cell carcinoma.

Authors:  Anu Jain; Chinmaya Narayana Kotimoole; Sushmita Ghoshal; Jaimanti Bakshi; Aditi Chatterjee; Thottethodi Subrahmanya Keshava Prasad; Arnab Pal
Journal:  Sci Rep       Date:  2021-02-09       Impact factor: 4.379

6.  Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms.

Authors:  Josiah Ochieng; Olga Y Korolkova; Guoliang Li; Renjie Jin; Zhenbang Chen; Robert J Matusik; Samuel Adunyah; Amos M Sakwe; Olugbemiga Ogunkua
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

7.  Alpha-2 Heremans Schmid Glycoprotein (AHSG) promotes the proliferation of bladder cancer cells by regulating the TGF-β signalling pathway.

Authors:  Yufei Dong; Dapeng Ding; Juebin Gu; Mingying Chen; Shijun Li
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

8.  Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors.

Authors:  Sarrah E Widatalla; Olga Y Korolkova; Diva S Whalen; J Shawn Goodwin; Kevin P Williams; Josiah Ochieng; Amos M Sakwe
Journal:  Carcinogenesis       Date:  2019-08-22       Impact factor: 4.944

9.  Impact of Fetuin-A, Lp(a), matrix gla protein and macrophage density on calcific aortic valve disease: a clinical study.

Authors:  Cong Liu; Haifeng Liu; Ting Xie
Journal:  Lipids Health Dis       Date:  2022-01-22       Impact factor: 3.876

10.  N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets.

Authors:  Guoqing Zhu; Feng Wang; Haojie Li; Xiao Zhang; Qi Wu; Ya Liu; Mingping Qian; Susu Guo; Yueyue Yang; Xiangfei Xue; Fenyong Sun; Yongxia Qiao; Qiuhui Pan
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.